Immunotherapy of cancer:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Totowa, NJ
Humana Press
2006
|
| Schriftenreihe: | Cancer drug discovery and development
|
| Schlagworte: | |
| Online-Zugang: | Table of contents Inhaltsverzeichnis |
| Beschreibung: | XII, 516 S. Ill., graph. Darst. |
| ISBN: | 1588295648 9781588295644 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV022469966 | ||
| 003 | DE-604 | ||
| 005 | 20070726 | ||
| 007 | t | ||
| 008 | 070619s2006 xxuad|| |||| 00||| eng d | ||
| 010 | |a 2005017065 | ||
| 020 | |a 1588295648 |c alk. paper |9 1-58829-564-8 | ||
| 020 | |a 9781588295644 |9 978-1-58829-564-4 | ||
| 035 | |a (OCoLC)60651107 | ||
| 035 | |a (DE-599)BVBBV022469966 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-355 | ||
| 050 | 0 | |a RC271.I45 | |
| 082 | 0 | |a 616.99/4061 | |
| 084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Immunotherapy of cancer |c ed. by Mary L. Disis |
| 264 | 1 | |a Totowa, NJ |b Humana Press |c 2006 | |
| 300 | |a XII, 516 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Cancer drug discovery and development | |
| 650 | 4 | |a Anticancéreux - Design | |
| 650 | 4 | |a Cancer - Immunothérapie | |
| 650 | 4 | |a Cancer |x Immunotherapy | |
| 650 | 4 | |a Antineoplastic agents |x Design | |
| 650 | 4 | |a Neoplasms |x immunology | |
| 650 | 4 | |a Neoplasms |x therapy | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Immuntherapie |0 (DE-588)4026640-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Immuntherapie |0 (DE-588)4026640-0 |D s |
| 689 | 0 | |C b |5 DE-604 | |
| 700 | 1 | |a Disis, Mary L. |e Sonstige |4 oth | |
| 856 | 4 | |u http://www.loc.gov/catdir/toc/ecip0514/2005017065.html |3 Table of contents | |
| 856 | 4 | 2 | |m LoC Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015677475&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015677475 | ||
Datensatz im Suchindex
| _version_ | 1804136556775079936 |
|---|---|
| adam_text | IMMUNOTHERAPY OF CANCER / DISIS, MARY L. : C2006 TABLE OF CONTENTS
/ INHALTSVERZEICHNIS DISCOVERY OF TARGET MOLECULES FOR CANCER
IMMUNOTHERAPY BY GENETIC AND BIOINFORMATIC APPROACHES CURRENT STRATEGIES
FOR THE IDENTIFICATION OF IMMUNOGENIC EPITOPES OF TUMOR ANTIGENS CURRENT
AND FUTURE ROLE OF NATURAL-KILLER CELLS IN CANCER IMMUNOTHERAPY THE ROLE
OF IMMUNE MONITORING IN EVALUATING CANCER IMMUNOTHERAPY STATISTICAL
ANALYSIS OF IMMUNE RESPONSE ASSAYS DNA VACCINES FOR CANCER IMMUNOTHERAPY
DENDRITIC CELLS DIFFERENT APPROACHES TO DENDRITIC CELL-BASED CANCER
IMMUNOTHERAPY ANTI-IDIOTYPE ANTIBODY VACCINES FOR THE IMMUNOTHERAPY OF
CANCER AUTOLOGOUS TUMOR-DERIVED HEAT SHOCK PROTEIN VACCINE AS A NEW
PARADIGM FOR INDIVIDUALIZED CANCER THERAPEUTICS TUMOR-REACTIVE T-CELLS
FOR ADOPTIVE IMMUNOTHERAPY T-CELL ADOPTIVE IMMUNOTHERAPY OF CANCER: FROM
TRANSLATIONAL MODELS TO CLINICAL SIGNIFICANCE RETROVIRAL-MEDIATED GENE
TRANSFER FOR ENGINEERING TUMOR-REACTIVE T-CELLS HARNESSING THE POTENTIAL
OF GRAFT-VS-TUMOR TUMOR-INDUCED IMMUNE SUPPRESSION AND IMMUNE ESCAPE:
MECHANISMS AND IMPACT ON THE OUTCOME OF IMMUNOTHERAPY OF MALIGNANT
DISEASE THE TUMOR MICROENVIRONMENT: REGULATION OF ANTITUMOR IMMUNITY AND
IMPLICATIONS FOR IMMUNOTHERAPY MANIPULATION OF LYMPHOCYTE HOMEOSTASIS
FOR ENHANCING ANTITUMOR IMMUNITY FAST-LANE EVOLUTION IN THE TUMOR
MICROENVIRONMENT MANIPULATING IMMUNOLOGICAL CHECKPOINTS TO MAXIMIZE
ANTITUMOR IMMUNITY INTERLEUKIN-2 AS CANCER THERAPY BIOLOGICAL AND
CLINICAL PROPERTIES OF THE TYPE 1 INTERFERONS PROMISING G [GAMMA]-CHAIN
CYTOKINES FOR CANCER IMMUNOTHERAPY: INTERLEUKINS-7, -15, AND -21 AS
VACCINE ADJUVANTS, GROWTH FACTORS THE THERAPEUTIC USE OF NATURAL-KILLER
CELLS IN HEMATOLOGICAL MALIGNANCIES ANTIBODY THERAPY FOR SOLID TUMORS
ANTIBODY THERAPY FOR NON-HODGKIN S LYMPHOMA APPROACHES TO IN VIVO
IMAGING OF CANCER IMMUNOTHERAPY DESIGN ISSUES FOR EARLY-STAGE CLINICAL
TRIALS FOR CANCER VACCINES MONOCLONAL ANTIBODY THERAPY FOR CANCER.
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
| adam_txt |
IMMUNOTHERAPY OF CANCER / DISIS, MARY L. : C2006 TABLE OF CONTENTS
/ INHALTSVERZEICHNIS DISCOVERY OF TARGET MOLECULES FOR CANCER
IMMUNOTHERAPY BY GENETIC AND BIOINFORMATIC APPROACHES CURRENT STRATEGIES
FOR THE IDENTIFICATION OF IMMUNOGENIC EPITOPES OF TUMOR ANTIGENS CURRENT
AND FUTURE ROLE OF NATURAL-KILLER CELLS IN CANCER IMMUNOTHERAPY THE ROLE
OF IMMUNE MONITORING IN EVALUATING CANCER IMMUNOTHERAPY STATISTICAL
ANALYSIS OF IMMUNE RESPONSE ASSAYS DNA VACCINES FOR CANCER IMMUNOTHERAPY
DENDRITIC CELLS DIFFERENT APPROACHES TO DENDRITIC CELL-BASED CANCER
IMMUNOTHERAPY ANTI-IDIOTYPE ANTIBODY VACCINES FOR THE IMMUNOTHERAPY OF
CANCER AUTOLOGOUS TUMOR-DERIVED HEAT SHOCK PROTEIN VACCINE AS A NEW
PARADIGM FOR INDIVIDUALIZED CANCER THERAPEUTICS TUMOR-REACTIVE T-CELLS
FOR ADOPTIVE IMMUNOTHERAPY T-CELL ADOPTIVE IMMUNOTHERAPY OF CANCER: FROM
TRANSLATIONAL MODELS TO CLINICAL SIGNIFICANCE RETROVIRAL-MEDIATED GENE
TRANSFER FOR ENGINEERING TUMOR-REACTIVE T-CELLS HARNESSING THE POTENTIAL
OF GRAFT-VS-TUMOR TUMOR-INDUCED IMMUNE SUPPRESSION AND IMMUNE ESCAPE:
MECHANISMS AND IMPACT ON THE OUTCOME OF IMMUNOTHERAPY OF MALIGNANT
DISEASE THE TUMOR MICROENVIRONMENT: REGULATION OF ANTITUMOR IMMUNITY AND
IMPLICATIONS FOR IMMUNOTHERAPY MANIPULATION OF LYMPHOCYTE HOMEOSTASIS
FOR ENHANCING ANTITUMOR IMMUNITY FAST-LANE EVOLUTION IN THE TUMOR
MICROENVIRONMENT MANIPULATING IMMUNOLOGICAL CHECKPOINTS TO MAXIMIZE
ANTITUMOR IMMUNITY INTERLEUKIN-2 AS CANCER THERAPY BIOLOGICAL AND
CLINICAL PROPERTIES OF THE TYPE 1 INTERFERONS PROMISING G [GAMMA]-CHAIN
CYTOKINES FOR CANCER IMMUNOTHERAPY: INTERLEUKINS-7, -15, AND -21 AS
VACCINE ADJUVANTS, GROWTH FACTORS THE THERAPEUTIC USE OF NATURAL-KILLER
CELLS IN HEMATOLOGICAL MALIGNANCIES ANTIBODY THERAPY FOR SOLID TUMORS
ANTIBODY THERAPY FOR NON-HODGKIN'S LYMPHOMA APPROACHES TO IN VIVO
IMAGING OF CANCER IMMUNOTHERAPY DESIGN ISSUES FOR EARLY-STAGE CLINICAL
TRIALS FOR CANCER VACCINES MONOCLONAL ANTIBODY THERAPY FOR CANCER.
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT. |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV022469966 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.I45 |
| callnumber-search | RC271.I45 |
| callnumber-sort | RC 3271 I45 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XH 3200 |
| ctrlnum | (OCoLC)60651107 (DE-599)BVBBV022469966 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01843nam a2200505zc 4500</leader><controlfield tag="001">BV022469966</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20070726 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">070619s2006 xxuad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2005017065</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1588295648</subfield><subfield code="c">alk. paper</subfield><subfield code="9">1-58829-564-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781588295644</subfield><subfield code="9">978-1-58829-564-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)60651107</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV022469966</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.I45</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunotherapy of cancer</subfield><subfield code="c">ed. by Mary L. Disis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 516 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cancer drug discovery and development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticancéreux - Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer - Immunothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Immunotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield><subfield code="x">Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunotherapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Disis, Mary L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/toc/ecip0514/2005017065.html</subfield><subfield code="3">Table of contents</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">LoC Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015677475&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015677475</subfield></datafield></record></collection> |
| id | DE-604.BV022469966 |
| illustrated | Illustrated |
| index_date | 2024-07-02T17:44:11Z |
| indexdate | 2024-07-09T20:58:17Z |
| institution | BVB |
| isbn | 1588295648 9781588295644 |
| language | English |
| lccn | 2005017065 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015677475 |
| oclc_num | 60651107 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | XII, 516 S. Ill., graph. Darst. |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | Humana Press |
| record_format | marc |
| series2 | Cancer drug discovery and development |
| spelling | Immunotherapy of cancer ed. by Mary L. Disis Totowa, NJ Humana Press 2006 XII, 516 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cancer drug discovery and development Anticancéreux - Design Cancer - Immunothérapie Cancer Immunotherapy Antineoplastic agents Design Neoplasms immunology Neoplasms therapy Immunotherapy Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Immuntherapie (DE-588)4026640-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Immuntherapie (DE-588)4026640-0 s b DE-604 Disis, Mary L. Sonstige oth http://www.loc.gov/catdir/toc/ecip0514/2005017065.html Table of contents LoC Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015677475&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Immunotherapy of cancer Anticancéreux - Design Cancer - Immunothérapie Cancer Immunotherapy Antineoplastic agents Design Neoplasms immunology Neoplasms therapy Immunotherapy Krebs Medizin (DE-588)4073781-0 gnd Immuntherapie (DE-588)4026640-0 gnd |
| subject_GND | (DE-588)4073781-0 (DE-588)4026640-0 |
| title | Immunotherapy of cancer |
| title_auth | Immunotherapy of cancer |
| title_exact_search | Immunotherapy of cancer |
| title_exact_search_txtP | Immunotherapy of cancer |
| title_full | Immunotherapy of cancer ed. by Mary L. Disis |
| title_fullStr | Immunotherapy of cancer ed. by Mary L. Disis |
| title_full_unstemmed | Immunotherapy of cancer ed. by Mary L. Disis |
| title_short | Immunotherapy of cancer |
| title_sort | immunotherapy of cancer |
| topic | Anticancéreux - Design Cancer - Immunothérapie Cancer Immunotherapy Antineoplastic agents Design Neoplasms immunology Neoplasms therapy Immunotherapy Krebs Medizin (DE-588)4073781-0 gnd Immuntherapie (DE-588)4026640-0 gnd |
| topic_facet | Anticancéreux - Design Cancer - Immunothérapie Cancer Immunotherapy Antineoplastic agents Design Neoplasms immunology Neoplasms therapy Immunotherapy Krebs Medizin Immuntherapie |
| url | http://www.loc.gov/catdir/toc/ecip0514/2005017065.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015677475&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT disismaryl immunotherapyofcancer |